Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-in Murine Models of Gaucher Disease

Version 1 : Received: 5 January 2024 / Approved: 8 January 2024 / Online: 8 January 2024 (16:15:52 CET)

A peer-reviewed article of this Preprint also exists.

Furderer, M.L.; Berhe, B.; Chen, T.C.; Wincovitch, S.; Jiang, X.; Tayebi, N.; Sidransky, E.; Han, T.-U. A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease. Int. J. Mol. Sci. 2024, 25, 1827. Furderer, M.L.; Berhe, B.; Chen, T.C.; Wincovitch, S.; Jiang, X.; Tayebi, N.; Sidransky, E.; Han, T.-U. A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease. Int. J. Mol. Sci. 2024, 25, 1827.

Abstract

Gaucher disease (GD) is a lysosomal storage disorder stemming from biallelic mutations in GBA1, characterized by glucocerebrosidase dysfunction and glucocerebroside and glucosylsphingosine accumulation. Since phenotypes of murine models of GD often differ from those in patients, careful characterization of Gba1 mutant mice is necessary to establish their ability to model GD. We performed side-by-side comparative biochemical and pathologic analyses of four murine Gba1 models with genotypes L444P/L444P (p.L483P/p.L483P), L444P/null, D409H/D409H (p.D448H/p.D448H), and D409H/null, along with matched wildtype mice, all with the same genetic background and cage conditions. All mutant mice exhibited significantly lower glucocerebrosidase activity (p < 0.0001) and higher glucosylsphingosine levels than wildtype, with the lowest glucocerebrosidase and highest glucosylsphingosine levels in mice carrying a null allele. Although glucocerebrosidase activity in L444P and D409H mice was similar, D409H mice showed more lipid accumulation. No Gaucher or storage-like cells were detected in any of the Gba1 mutant mice. Quantification of neuroinflammation, dopaminergic neuronal loss, alpha-synuclein levels and motor behavior revealed no significant findings, even in aged animals. Thus, while the models may have utility for testing the effect of different therapies on enzymatic activity, they did not recapitulate the pathological phenotype of patients with GD, and better models are needed.

Keywords

Gaucher disease; glucocerebrosidase; neuropathology; glucosylsphingosine; murine models; Parkinson disease

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.